Viridian Therapeutics (VRDN) News Today $15.59 +0.36 (+2.34%) As of 01:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRDN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Viridian Therapeutics (NASDAQ:VRDN) Shares Down 4.5% - What's Next?June 17, 2025 | marketbeat.comViridian Therapeutics’ SWOT analysis: promising TED treatment stock faces pivotal yearJune 15, 2025 | investing.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by AnalystsJune 12, 2025 | marketbeat.comViridian Therapeutics: The Song Remains The SameJune 9, 2025 | seekingalpha.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.22 Million Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN)June 7, 2025 | marketbeat.comViridian Therapeutics to Participate in Upcoming June Investor ConferencesMay 30, 2025 | businesswire.comBank of America Corp DE Grows Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 30, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Holdings Increased by Nuveen Asset Management LLCMay 28, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Millennium Management LLCMay 28, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 109,231 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 27, 2025 | marketbeat.comTwo Sigma Investments LP Sells 57,599 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 27, 2025 | marketbeat.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Sells 209,818 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 22, 2025 | marketbeat.comViridian Therapeutics’ SWOT analysis: promising TED treatment stock faces key catalystsMay 21, 2025 | investing.comSoleus Capital Management L.P. Sells 49,500 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 21, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Bought by Rafferty Asset Management LLCMay 21, 2025 | marketbeat.comTang Capital Management LLC Raises Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 20, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 20, 2025 | marketbeat.comDeutsche Bank AG Increases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 20, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $8.47 Million Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 18, 2025 | marketbeat.comNorthern Trust Corp Boosts Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 18, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 271,156 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 18, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires New Shares in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 17, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Bought by The Manufacturers Life Insurance CompanyMay 17, 2025 | marketbeat.comParadigm Biocapital Advisors LP Sells 1,075,610 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Has $20.85 Million Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 16, 2025 | marketbeat.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes $855,000 Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 16, 2025 | marketbeat.comBalyasny Asset Management L.P. Sells 208,368 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 15, 2025 | marketbeat.comB. Riley Lifts Earnings Estimates for Viridian TherapeuticsMay 11, 2025 | marketbeat.comHC Wainwright Analysts Cut Earnings Estimates for VRDNMay 11, 2025 | marketbeat.comQ2 EPS Estimate for Viridian Therapeutics Cut by AnalystMay 11, 2025 | marketbeat.comQ2 EPS Forecast for Viridian Therapeutics Boosted by AnalystMay 11, 2025 | marketbeat.comDriehaus Capital Management LLC Decreases Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 11, 2025 | marketbeat.comQ1 Earnings Forecast for VRDN Issued By HC WainwrightMay 10, 2025 | marketbeat.comConcentric Capital Strategies LP Makes New Investment in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 10, 2025 | marketbeat.comNeedham & Company LLC Lowers Viridian Therapeutics (NASDAQ:VRDN) Price Target to $36.00May 9, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) is Deep Track Capital LP's 9th Largest PositionMay 9, 2025 | marketbeat.comViridian Therapeutics (VRDN) Projected to Post Quarterly Earnings on WednesdayMay 9, 2025 | marketbeat.comCrestline Management LP Purchases 48,315 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 9, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Announces Earnings Results, Beats Expectations By $0.08 EPSMay 8, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Bought by Cutter Capital Management LPMay 8, 2025 | marketbeat.comBraidwell LP Buys Shares of 34,094 Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 8, 2025 | marketbeat.comViridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (TED)May 7, 2025 | finance.yahoo.comViridian Therapeutics shares fall as Q1 loss narrows, revenue beatsMay 6, 2025 | in.investing.comViridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial ResultsMay 6, 2025 | finance.yahoo.comNovo Holdings A S Sells 135,000 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 3, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Reduces Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)May 3, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Acquired by Price T Rowe Associates Inc. MDMay 3, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Barclays PLCMay 2, 2025 | marketbeat.comLord Abbett & CO. LLC Raises Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)April 30, 2025 | marketbeat.comTower Research Capital LLC TRC Raises Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)April 30, 2025 | marketbeat.com Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address VRDN Media Mentions By Week VRDN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRDN News Sentiment▼0.000.57▲Average Medical News Sentiment VRDN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRDN Articles This Week▼05▲VRDN Articles Average Week Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RDNT News Today BTSG News Today SHC News Today SGRY News Today CON News Today PRVA News Today WGS News Today VCYT News Today ADUS News Today LFST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRDN) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
